Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chiho, Furuya"'
Autor:
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Yasutaka Fukuda, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objectives: Hemorrhagic events are a rare but potentially fatal complication in patients with polycythemia vera (PV).Methods: We analyzed the characteristics of hemorrhagic events in 267 patients with PV.Results: A median follow-up of 4.8 years revea
Externí odkaz:
https://doaj.org/article/c6726a573a5b4acd90acf1788fe3a99c
Autor:
Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, Tadaaki Inano, Tomoiku Takaku, Yasuharu Hamano, Miki Ando
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Persistent COVID-19 is a well recognized issue of concern in patients with hematological malignancies. Such patients are not only at risk of mortality due to the infection itself, but are also at risk of suboptimal malignancy-related outcomes because
Externí odkaz:
https://doaj.org/article/35e8342eba5e41138270db7584b65e50
Autor:
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives Since MPL mutation is a rare driver gene mutation found in a small number of essential thrombocythemia (ET) patients, the clinical characteristics of patients with MPL mutations and their association with thrombotic events have not
Externí odkaz:
https://doaj.org/article/813cf5ec16284642b53a3a2163c87d5d
Autor:
Soji Morishita, Yoshinori Hashimoto, Chiho Furuya, Yoko Edahiro, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Hajime Yasuda, Miki Ando, Marito Araki, Norio Komatsu
Publikováno v:
European Journal of Haematology. 110:131-136
A proportion of patients with polycythemia vera (PV) and essential thrombocythemia (ET) harbor non-driver mutations associated with poor prognosis. In this study, we analyzed the frequency of non-driver mutations in a large Japanese PV and ET cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03d9eb3872e6df8adbe9ddd9b6fc315
https://doi.org/10.1111/ejh.13882
https://doi.org/10.1111/ejh.13882
Autor:
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, Motoaki Shiratsuchi, Kei Nakajima, Eiichi Ohtsuka, Hiroaki Tanaka, Eri Kawata, Mika Nakamae, Yasunori Ueda, Yasuo Aota, Yasumasa Sugita, Shin Ohara, Satoshi Yamasaki, Kohsuke Asagoe, Shuro Yoshida, Jun Yamanouchi, Sayaka Suzuki, Toshinori Kondo, Yuji Kanisawa, Kohtaro Toyama, Hiromi Omura, Daisuke Mizuchi, Sumio Sakamaki, Miki Ando, Norio Komatsu
Publikováno v:
International Journal of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa16ee5ffeb73612d1d28dca7b68d44
https://doi.org/10.1007/s12185-023-03592-0
https://doi.org/10.1007/s12185-023-03592-0
Autor:
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
Publikováno v:
Journal of thrombosis and thrombolysis.
Risk-adapted therapy is recommended to prevent thrombosis in essential thrombocythemia (ET) patients. An advanced age, a history of thrombosis, and the presence of the JAK2V617F mutation are well-defined risk factors for thrombosis in ET; however, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9157116c421afb761c69307698621e
https://pubmed.ncbi.nlm.nih.gov/36484956
https://pubmed.ncbi.nlm.nih.gov/36484956
Autor:
Yasutaka, Fukuda, Yoko, Edahiro, Tomoiku, Takaku, Chiho, Furuya, Shuichi, Shirane, Yasuharu, Hamano, Michiaki, Koike, Norio, Komatsu
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(1)
Immunosuppressive therapies, including antithymocyte globulin and cyclosporine (CsA), are used for the treatment of aplastic anemia, but they reportedly cause lymphoproliferative diseases. Here, we report two cases of aplastic anemia in which diffuse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bb44ea4452a644f3495ba01d7d5908c
https://pubmed.ncbi.nlm.nih.gov/35135947
https://pubmed.ncbi.nlm.nih.gov/35135947
Autor:
Federico, De Marchi, Maho, Okuda, Soji, Morishita, Misa, Imai, Terumi, Baba, Mei, Horino, Yosuke, Mori, Chiho, Furuya, Satoko, Ogata, Yinjie, Yang, Jun, Ando, Miki, Ando, Marito, Araki, Norio, Komatsu
Publikováno v:
Leukemia Research. 119:106883
Cyclic AMP-response element-binding protein 3-like 1 (CREB3L1) is a gene involved in the unfolded protein response (UPR). Recently, we demonstrated that CREB3L1 is specifically overexpressed in the platelets of patients with Philadelphia chromosome-n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b373c58620879d779e1aa0566d2be3
https://doi.org/10.1016/j.leukres.2022.106883
https://doi.org/10.1016/j.leukres.2022.106883
Autor:
Shuichi, Shirane, Yasuharu, Hamano, Chiho, Furuya, Tadahiro, Honda, Makoto, Sasaki, Norio, Komatsu
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(2)
We report the case of a 58-year-old woman with multiple myeloma who relapsed after the first autologous peripheral blood stem cell transplantation. She was refractory to new drugs and underwent a haploidentical allogeneic hematopoietic stem cell tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3280d1e15946f770069ea8680f4805e6
https://pubmed.ncbi.nlm.nih.gov/33678775
https://pubmed.ncbi.nlm.nih.gov/33678775